Showing results (61-70 of 76) with videos related to

Sort By:
Pageof 8
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|March 5, 2022
Sentinel lymph node melanoma metastases: Assessment of tumor burden for clinical prediction of outcome in the first Multicenter Selective Lymphadenectomy Trial (MSLT-I)Alistair J Cochran, Duan-Ren Wen, Rong-Rong Huang, et al.
Annals of Surgical Oncology|July 9, 2010
The impact on morbidity and length of stay of early versus delayed complete lymphadenectomy in melanoma: results of the Multicenter Selective Lymphadenectomy Trial (I)Mark B Faries, John F Thompson, Alistair Cochran, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 8, 2010
Serial monitoring of circulating tumor cells predicts outcome of induction biochemotherapy plus maintenance biotherapy for metastatic melanomaKazuo Koyanagi, Steven J O'Day, Peter Boasberg, et al.
The New England Journal of Medicine|September 29, 2006
Sentinel-node biopsy or nodal observation in melanomaDonald L Morton, John F Thompson, Alistair J Cochran, et al.
Neuro-Oncology|August 31, 2016
Human TERT promoter mutation enables survival advantage from MGMT promoter methylation in IDH1 wild-type primary glioblastoma treated by standard chemoradiotherapyHuyTram N Nguyen, Amy Lie, Tie Li, et al.
Annals of Surgery|October 9, 2002
Prolonged survival of patients receiving active immunotherapy with Canvaxin therapeutic polyvalent vaccine after complete resection of melanoma metastatic to regional lymph nodesDonald L Morton, Eddy C Hsueh, Richard Essner, et al.
Annals of Surgery|September 2, 2005
Sentinel node biopsy for early-stage melanoma: accuracy and morbidity in MSLT-I, an international multicenter trialDonald L Morton, Alistair J Cochran, John F Thompson, et al.
Journal of the National Cancer Institute|October 2, 2014
Prognostic and therapeutic relevance of molecular subtypes in high-grade serous ovarian cancerGottfried E Konecny, Chen Wang, Habib Hamidi, et al.
Journal of the National Cancer Institute|August 5, 2004
Her-2/neu gene amplification and response to paclitaxel in patients with metastatic breast cancerGottfried E Konecny, Christoph Thomssen, Hans Joachim Lück, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 1, 2011
Expression of p16 and retinoblastoma determines response to CDK4/6 inhibition in ovarian cancerGottfried E Konecny, Boris Winterhoff, Teodora Kolarova, et al.
Pageof 8